File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine

TitleEpidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine
Authors
Issue Date2017
PublisherEuropean Centre for Disease Prevention and Control. The Journal's web site is located at http://www.eurosurveillance.org/Public/AboutUs/AboutUs.aspx
Citation
Eurosurveillance, 2017, v. 22 n. 50, article no. 16-00824 How to Cite?
AbstractIntroduction: Hand, foot and mouth disease (HFMD) is usually caused by several serotypes from human enterovirus A species, including enterovirus 71 (EV-A71) and coxsackievirus A16 (CV-A16). Two inactivated monovalent EV-A71 vaccines have been recently licensed in China and monovalent CV-A16 vaccine and bivalent EV-A71 and CV-A16 vaccine are under development. Methods: Using notifications from the national surveillance system, we describe the epidemiology and dynamics of HFMD in the country, before the introduction of EV-A71 vaccination, from 2008 through 2015. Results: Laboratory-identified serotype categories, i.e. CV-A16, EV-A71 and other enteroviruses, circulated annually. EV-A71 remained the most virulent serotype and was the major serotype for fatal cases (range: 88.5–95.4%) and severe cases (range: 50.7– 82.3%) across years. Except for 2013 and 2015, when other enteroviruses were more frequently found in mild HFMD (48.8% and 52.5%), EV-A71 was more frequently detected from mild cases in the rest of the years covered by the study (range: 39.4–52.6%). The incidence rates and severity risks of HFMD associated with all serotype categories were the highest for children aged 1 year and younger, and decreased with increasing age. Discussion/conclusion: This study provides baseline epidemiology for evaluation of vaccine impact and potential serotype replacement.
Persistent Identifierhttp://hdl.handle.net/10722/261635
ISSN
2021 Impact Factor: 21.286
2020 SCImago Journal Rankings: 2.766
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorYang, B-
dc.contributor.authorLiu, F-
dc.contributor.authorLiao, Q-
dc.contributor.authorWu, P-
dc.contributor.authorChang, Z-
dc.contributor.authorHuang, J-
dc.contributor.authorLong, L-
dc.contributor.authorLuo, L-
dc.contributor.authorLi, Y-
dc.contributor.authorLeung, GM-
dc.contributor.authorCowling, BJ-
dc.contributor.authorYu, H-
dc.date.accessioned2018-09-28T04:45:04Z-
dc.date.available2018-09-28T04:45:04Z-
dc.date.issued2017-
dc.identifier.citationEurosurveillance, 2017, v. 22 n. 50, article no. 16-00824-
dc.identifier.issn1025-496X-
dc.identifier.urihttp://hdl.handle.net/10722/261635-
dc.description.abstractIntroduction: Hand, foot and mouth disease (HFMD) is usually caused by several serotypes from human enterovirus A species, including enterovirus 71 (EV-A71) and coxsackievirus A16 (CV-A16). Two inactivated monovalent EV-A71 vaccines have been recently licensed in China and monovalent CV-A16 vaccine and bivalent EV-A71 and CV-A16 vaccine are under development. Methods: Using notifications from the national surveillance system, we describe the epidemiology and dynamics of HFMD in the country, before the introduction of EV-A71 vaccination, from 2008 through 2015. Results: Laboratory-identified serotype categories, i.e. CV-A16, EV-A71 and other enteroviruses, circulated annually. EV-A71 remained the most virulent serotype and was the major serotype for fatal cases (range: 88.5–95.4%) and severe cases (range: 50.7– 82.3%) across years. Except for 2013 and 2015, when other enteroviruses were more frequently found in mild HFMD (48.8% and 52.5%), EV-A71 was more frequently detected from mild cases in the rest of the years covered by the study (range: 39.4–52.6%). The incidence rates and severity risks of HFMD associated with all serotype categories were the highest for children aged 1 year and younger, and decreased with increasing age. Discussion/conclusion: This study provides baseline epidemiology for evaluation of vaccine impact and potential serotype replacement.-
dc.languageeng-
dc.publisherEuropean Centre for Disease Prevention and Control. The Journal's web site is located at http://www.eurosurveillance.org/Public/AboutUs/AboutUs.aspx-
dc.relation.ispartofEurosurveillance-
dc.rightsEurosurveillance. Copyright © European Centre for Disease Prevention and Control.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleEpidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine-
dc.typeArticle-
dc.identifier.emailWu, P: pengwu@hku.hk-
dc.identifier.emailLeung, GM: gmleung@hku.hk-
dc.identifier.emailCowling, BJ: bcowling@hku.hk-
dc.identifier.authorityWu, P=rp02025-
dc.identifier.authorityLeung, GM=rp00460-
dc.identifier.authorityCowling, BJ=rp01326-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.2807/1560-7917.ES.2017.22.50.16-00824-
dc.identifier.pmid29258646-
dc.identifier.pmcidPMC5743100-
dc.identifier.scopuseid_2-s2.0-85039035088-
dc.identifier.hkuros292651-
dc.identifier.volume22-
dc.identifier.issue50-
dc.identifier.spagearticle no. 16-00824-
dc.identifier.epagearticle no. 16-00824-
dc.identifier.isiWOS:000418086600006-
dc.publisher.placeSweden-
dc.identifier.issnl1025-496X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats